Categories: National

Elsevier Analysis Reveals ‘Brain Gain’ Rather Than ‘Brain Drain’ for India

Results announced during Centennial Indian Science Congress 3-7 January 2013 held in Kolkata

Kolkata, West Bengal, India, Friday, January 04, 2013 — (Business Wire India) — A recent analysis by Elsevier shows that India has a 0.6% net inflow of scientists. Moreover, incoming scientists and short-term visiting (or transitory) scientists are significantly more productive than scientists who remain in India and scientists that leave the country. India is not losing productive brains, but is in fact an importer of productive brains.

Dr. Michiel Kolman, Senior Vice-President Academic Relations at Elsevier, attending the Centennial Indian Science Congress, commented, “India shows a net inflow of scientists, with the productivity of the incoming and visiting scientists being higher than that of the average staying and outgoing scientist; so in fact a case can be made for an Indian ‘Brain Gain’ rather than the commonly believed ‘Brain Drain’.”

Using Elsevier’s Scopus database, publication data was studied over a 15 year period tracking migration streams of scientists using their affiliations and hence the country they publish in. The size of the migration streams was analyzed revealing that 64.1% of the scientists stayed within India during the 15 year study period, 23.4% were visiting (or transitory) researchers (traveling in or out of India for a period less than 2 years), 6.6% moved to and 6.0% left India; summing up to a net inflow of 0.6%.

The level of productivity of these migration groups was measured by publication output and expressed relative to India’s country average publication output set to one. Analyses showed that incoming scientists (6.6% of the total number of scientists studied) are most productive (1.38 where 1.00 is the average publication output for India), visiting or transitory scientists (23.4%) are almost as productive (1.34), while outgoing scientists (6.0%) are below average in productivity (0.95).

These results can be put into international context by comparison with the UK and China. Both the UK and China display similar patterns as India: all three countries import scientists that are more productive than their country average and they all export scientists that are less productive.

Group size comparative analyses of outgoing scientists revealed: 6.0% for India, 10.0% for UK and 2.1% for China; with productivity levels at 0.95, 0.92 and 0.99 respectively, consistently below country publication average for all three countries.

Group size comparative analyses of incoming scientists revealed: 6.6% for India, 8.5% for UK and 7.1% for China; with productivity levels at 1.38, 1.14 and 1.85 respectively; consistently higher than country publication average for all three countries, and significantly higher for India and China.

Group size comparative analyses of visiting (or transitory) scientists revealed: 23.4% for India, 44.4% for UK and 16.0% for China, with productivity levels at 1.34, 1.24 and 1.22 respectively; again more productive than country publication averages.

Group size comparative analyses of staying scientists in the15 year study period revealed: 64.1% for India, 37.2% for UK and 74.9% for China, with productivity levels 0.75, 0.60 and 0.74 respectively; all significantly below the country averages, with the UK being the least productive.

Further comparing level of mobility (incoming, visiting and outgoing), it was found that mobility is substantially higher for the UK compared to China or India with 62.8% of all scientists from the UK moving around during the 15 year study period, compared to 35.9% for India and 25.1% for China.

About Elsevier

Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include ScienceDirect, Scopus, Reaxys, ClinicalKey and Mosby’s Nursing Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai’s Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

CONTACT DETAILS
Manik Sethi, Elsevier India, +91 9910225543, m.sethi@elsevier.com

The Pharma Times News Bureau

Recent Posts

World Diabetes Day Survey: Diabetologists and Endocrinologists demand for AI-Based Training and Upskilling in Diabetes Care

 A striking 90% of the 3000 Diabetologists and Endocrinologists surveyed, emphasised the importance of continuous…

1 day ago

Doctors warn diabetes patients about risk of smoking

People who smoke are also at much higher risk of developing diabetes compared to non-smokers…

2 days ago

CPHI & PMEC India Expo: Encouraging affordable solutions in India’s march towards a $130 Billion Pharma Market by 2030

17th edition of CPHI& PMEC India Expo to be held from 26th November-28thNovember 2024, at the India…

2 days ago

Sringeri Sharada Equitas Hospital Revolutionizing Cancer Care with the Launch of Low-cost, High Quality Radiation Therapy

The launch signifies Equitas’ redefined commitment to bring world-class cancer radiation therapy accessible to all.…

3 days ago